about
What we truly know about occupation as a risk factor for ALS: A critical and systematic reviewDrug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIIntravenous immunoglobulin for multifocal motor neuropathyMultiple common variants for celiac disease influencing immune gene expressionMutations in the profilin 1 gene cause familial amyotrophic lateral sclerosisWhole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosisCold paresis in multifocal motor neuropathyGenome-wide association study of intracranial aneurysm identifies three new risk lociSusceptibility loci for intracranial aneurysm in European and Japanese populationsAssociations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic reviewNEK1 variants confer susceptibility to amyotrophic lateral sclerosisImpaired structural motor connectome in amyotrophic lateral sclerosisMeta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosisITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association studyAge of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1.A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.The changing picture of amyotrophic lateral sclerosis: lessons from European registers.Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis.The verbal fluency index: Dutch normative data for cognitive testing in ALS.Markov Models for inferring copy number variations from genotype data on Illumina platformsGene-network analysis identifies susceptibility genes related to glycobiology in autismWeighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patientsA blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.Is human blood a good surrogate for brain tissue in transcriptional studies?Aging effects on DNA methylation modules in human brain and blood tissue.Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study.Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival studyIntravenous immunoglobulin treatment in multifocal motor neuropathy.Effects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trialTrans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLAC9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysisA sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder.Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression.
P50
Q22305680-3172501B-D574-432D-B3E2-258D38CC0AF3Q24200270-4D9D2F67-ADE7-40EB-B272-0B12E3E578CDQ24200377-E686F82C-F442-46CC-B601-3744A2FB8A4BQ24234414-17C7DBD8-032F-4E40-8BD7-33EA0CF36992Q24234523-904BAEEC-259C-4F76-B743-9BA4AB3803C0Q24241017-814A49BF-CEE4-44A5-9517-04CCE0274AEAQ24241759-625CFA8B-57A8-4EA2-80EA-D7E404B58EE5Q24247007-D6B359C4-946D-4B76-9535-14BF96431407Q24608614-2D5BA893-53E1-4695-83B2-84211EC2F650Q24619298-0BDC8CFA-A787-48DC-8F4F-59B5FAF6FF0FQ24623830-FD85E3CE-DB68-410D-A65E-EF2F877DB67BQ24628273-FFB77F24-245B-4043-907B-7CB5A2585BDEQ24630663-77F1362A-3C8F-4C5B-9911-F822E1A78816Q24643743-E7987E16-31E8-4B39-856B-5665C5BB868BQ26738679-3DFAC16A-678A-4206-B8E7-E4BC0351D0EEQ28277378-C6F7800D-32D2-4062-AB92-4AD3754A2E1AQ28740801-03297A06-7F7B-444F-8391-C6CA066D18B5Q28943305-F4C5260F-CE59-4454-89F0-CCFBEDC46A66Q28943310-DC1200FE-C342-423A-9DAF-1B88ED648CC5Q28943532-F9A6E320-D4A0-4942-A0F6-7A01B70ECB05Q29417029-0039216D-DC92-4877-894F-23E76DB19A56Q29417136-3C21BA68-B7D9-45A8-B50A-C1C1997350EFQ30235329-3D9BD448-C0E5-4765-BC39-13A3F41DFF7AQ30365956-8E2832A3-3382-4DF6-9A77-E2957E04CF54Q30826845-F2364BD7-A18F-41C8-94D8-5B8CCB45D5A5Q33425649-42CA9512-78FB-42EB-98D5-58F22F0513CAQ33459263-802899E5-34C7-41C6-A4EB-60C38FB17A60Q33497640-BC836AD9-75D8-424B-8941-A41FA940046FQ33658563-7FB727DF-394E-4D1C-8877-84A2AECFD7D7Q33723516-C187D816-107F-4409-9622-C3A62B8D0FC8Q33741734-4DEA8E2E-D0F7-44A0-8C06-A24BD599B5B0Q33741815-54310F82-8FA3-4603-9104-201720BC1E74Q33870202-19727A72-A45C-4FD3-91E2-ABB1FB17696EQ33903466-2D8FA379-B302-4327-A9D7-63CC93C25685Q33932196-31DDC693-F126-4B17-B24F-BC0ADCB5F872Q33987569-3594C0B3-B910-40F9-9741-7D6FDF957912Q34063137-F7A446A2-85E5-4B09-9AF4-2E6161175878Q34071175-C285F7E6-7A89-4A43-824F-2BFB8BDA029BQ34104731-CBC08C22-DE65-4E21-A73C-000BDE339BA9Q34139984-69526070-FB6E-4905-9224-94AB94AE04F9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Leonard H van den Berg
@ast
Leonard H van den Berg
@en
Leonard H van den Berg
@es
Leonard H van den Berg
@nl
type
label
Leonard H van den Berg
@ast
Leonard H van den Berg
@en
Leonard H van den Berg
@es
Leonard H van den Berg
@nl
altLabel
Leonard van den Berg
@nl
prefLabel
Leonard H van den Berg
@ast
Leonard H van den Berg
@en
Leonard H van den Berg
@es
Leonard H van den Berg
@nl
P106
P21
P31
P496
0000-0002-6559-3965